Valuation: BICO Group AB

Market Cap 1.7B 170M 152M 141M 128M 239M 16.22B 243M 671M 8.48B 640M 626M 26.86B P/E 2026 *
-22.9x
P/E 2027 * -11.7x
Enterprise Value 1.53B 154M 137M 127M 115M 215M 14.61B 219M 605M 7.64B 576M 564M 24.19B EV / Sales 2026 *
0.92x
EV / Sales 2027 * 0.9x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day-5.26%
1 week-5.26%
Current month+32.11%
1 month+32.11%
3 months+81.56%
6 months+14.30%
Current year+20.54%
1 month 0.67
Extreme 0.66963
0.71
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.71
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
13.31
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member 51 07/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
-5.26%-5.26% - - 171M
+0.96%+0.09%+20.62%+54.49% 249B
+0.60%+3.40%+5.00%+19.81% 162B
-0.32%+3.97%-18.30%+73.55% 157B
-0.40%+0.88%-55.63%-8.71% 66.22B
-1.57%+0.45%+7.62%+67.36% 52.3B
+1.03%+3.07%-14.53%-8.28% 52.18B
+1.54%+3.76%+11.98%+44.15% 51.34B
+1.41%+3.11%+19.51%+67.95% 48.79B
+0.27%+4.65%+29.20%+85.91% 44.57B
Average -0.22%+2.12%+0.61%+44.03% 98.17B
Weighted average by Cap. +0.41%+1.40%+2.15%+45.55%

Financials

2026 *2027 *
Net sales 1.66B 167M 149M 138M 125M 234M 15.88B 238M 657M 8.31B 627M 613M 26.3B 1.64B 165M 148M 136M 124M 231M 15.7B 235M 650M 8.21B 619M 606M 26B
Net income -74M -7.43M -6.65M -6.15M -5.57M -10.42M -707M -10.59M -29.27M -370M -27.9M -27.3M -1.17B -144M -14.46M -12.93M -11.97M -10.83M -20.28M -1.38B -20.61M -56.96M -720M -54.29M -53.13M -2.28B
Net Debt -169M -16.98M -15.18M -14.04M -12.72M -23.8M -1.62B -24.19M -66.85M -845M -63.71M -62.35M -2.67B -227M -22.8M -20.39M -18.86M -17.08M -31.97M -2.17B -32.49M -89.79M -1.13B -85.58M -83.75M -3.59B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
24.05SEK
Average target price
31.00SEK
Spread / Average Target
+28.90%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB